Recruiting
Phase 2

A Study of Zolbetuximab (IMAB362) in Adults With Gastric Cancer

Sponsor:

Astellas Pharma Global Development, Inc.

Code:

NCT03505320

Conditions

Pharmacokinetics of Zolbetuximab

Gastric Cancer

Gastro-esophageal Junction (GEJ) Cancer

Pharmacokinetics of Oxaliplatin

Pharmacokinetics of Fluorouracil Bolus (5-FU)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

zolbetuximab

oxaliplatin

leucovorin

fluorouracil

Pembrolizumab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information